title: Minimal residual disease cells in AML patients have an apoptosis-sensitive protein profile.
authors.forename: A
authors.initials: A
authors.lastname: van Stijn
authors.forename: A
authors.initials: A
authors.lastname: Kok
authors.forename: M A
authors.initials: MA
authors.lastname: van Stalborch
authors.forename: M A
authors.initials: MA
authors.lastname: van Der Pol
authors.forename: N
authors.initials: N
authors.lastname: Feller
authors.forename: A H
authors.initials: AH
authors.lastname: Westra
authors.forename: G J
authors.initials: GJ
authors.lastname: Ossenkoppele
authors.forename: G J
authors.initials: GJ
authors.lastname: Schuurhuis
mesh_terms: D000208:Acute Disease; D017209:Apoptosis; D004351:Drug Resistance; D006801:Humans; D007951:Leukemia, Myeloid / Q000473:pathology*; D009363:Neoplasm Proteins / Q000032:analysis; D018365:Neoplasm, Residual / Q000209:etiology* / Q000473:pathology; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000032:analysis
chemical_list: D009363:Neoplasm Proteins; D019253:Proto-Oncogene Proteins c-bcl-2